Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Non-Invasive Glucose Monitoring Devices Market: By Technology, Optical Coherence Tomography, Occlusion Spectroscopy, Thermal Emission Spectroscopy, Impedance/Dielectric Spectroscopy, Photoacoustic Spectroscopy, Electromagnetic, Fluorescence, Polarimetry), By Modality, By End User, and Geography
Non-Invasive Glucose Monitoring Devices Market size was valued at US$ 19.7 million in 2023 and is poised to grow at a significant CAGR of 30% from 2024-2030. The non-Invasive Glucose Monitoring Devices Market has many market players and highly fragmented. Market players invest on product innovations to sustain their position in the market. In addition collaborations and acquisitions are key strategies used by market players to increase their market share. For example in 2014, NovioSense had created smaller than usual electrochemical sensor that empower non-obtrusive glucose checking and is equipped for identifying glucose focus in human tears. Technological progressions and expanding FDA endorsement for observing gadgets is required to give lucrative development chances to showcase players in coming years.
For example, the advancement of new checking gadgets, for example, GlucoTrack which is a non-obtrusive blood glucose screen that clasps to ear cartilage consequently disposing of the requirement for day by day finger pricks.Systemic Lupus Erythematosus (SLE) is an immune system infection that influences different organ frameworks of the body, and its side effects go from general disquietude to genuine, CNS and renal indications. Presently, there are restricted treatment choices accessible to treat the condition. Corticosteroids, hydroxychloroquine, and ordinary immunosuppressant are the pillar of treatment for SLE. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient's glucose level on a continuous basis. Non-invasive blood glucose monitoring devices require fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets at home to monitor their blood glucose levels. Noninvasive glucose monitoring reduces the necessity for unpleasant pricking, which increases the risk of infection and the amount of damage to finger tissue.
Study Period
2024-2030Base Year
2023CAGR
30%Largest Market
North AmericaFastest Growing Market
North America
Non-Invasive Glucose Monitoring Devices market is driven by high incidence of diabetes worldwide. According to WHO, prevalence of diabetes among adults over 18 years of age to have risen from 4.7% in 2012 to 8.5% by 2014. It also projects high blood glucose level and diabetes to be the 7th leading cause of death in 2030. In addition technological advancements in glucose measuring devices such as evolution of continuous glucose monitoring devices are propelling the growth of Non-Invasive Glucose Monitoring Devices market. Furthermore increase in demand for portable self-glucose measuring devices, increase in R&D investment and government funding in prevention and treatment of diabetes are expected to bolster the Non-Invasive Glucose Monitoring Devices globally
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 19.7 million |
Market CAGR |
30% |
By Technology |
|
By Modality |
|
By End User |
|
Download Free Sample Report
The global non invasive glucose monitoring devices market size was valued at US$ 19.7 million in 2023 and is projected to grow at a CAGR of 30% by 2030.
Abbott Laboratories (U.S.), ARKRAY, Inc. (Japan), Bayer AG (Germany), Dexcom, Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland)
North America is the fastest-growing region for non-invasive glucose monitoring devices market
Non-Invasive Glucose Monitoring Devices Market size was valued at US$ 18 million in 2022 and is expected to reach US$ 98.1 million by 2029 growing at a CAGR of 30% from 2023-2029.
The non-invasive glucose monitoring devices market is experiencing significant growth driven by the increasing demand for painless and continuous blood glucose monitoring solutions, technological advancements, and a rising diabetic population.
1.Executive Summary |
2.Global Non-Invasive Glucose Monitoring Devices Market Introduction |
2.1.Global Non-Invasive Glucose Monitoring Devices Market - Taxonomy |
2.2.Global Non-Invasive Glucose Monitoring Devices Market - Definitions |
2.2.1.Technology |
2.2.2.Modality |
2.2.3.End User |
2.2.4.Region |
3.Global Non-Invasive Glucose Monitoring Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Non-Invasive Glucose Monitoring Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Non-Invasive Glucose Monitoring Devices Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Raman Spectroscopy |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. MIR/NIR (Mid/Near Infrared Spectroscopy) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Optical Coherence Tomography |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Occlusion Spectroscopy |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Thermal Emission Spectroscopy |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Impedance/Dielectric Spectroscopy |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Photoacoustic Spectroscopy |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Electromagnetic |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Fluorescence |
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Polarimetry |
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
6.Global Non-Invasive Glucose Monitoring Devices Market By Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Wearable |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Non wearable |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Non-Invasive Glucose Monitoring Devices Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic centres |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Home Care |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Ambulatory surgical centres |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Non-Invasive Glucose Monitoring Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Non-Invasive Glucose Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Raman Spectroscopy |
9.1.2.MIR/NIR (Mid/Near Infrared Spectroscopy) |
9.1.3.Optical Coherence Tomography |
9.1.4.Occlusion Spectroscopy |
9.1.5.Thermal Emission Spectroscopy |
9.1.6.Impedance/Dielectric Spectroscopy |
9.1.7.Photoacoustic Spectroscopy |
9.1.8.Electromagnetic |
9.1.9.Fluorescence |
9.1.10.Polarimetry |
9.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Wearable |
9.2.2.Non wearable |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Diagnostic centres |
9.3.3.Home Care |
9.3.4.Ambulatory surgical centres |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Non-Invasive Glucose Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Raman Spectroscopy |
10.1.2.MIR/NIR (Mid/Near Infrared Spectroscopy) |
10.1.3.Optical Coherence Tomography |
10.1.4.Occlusion Spectroscopy |
10.1.5.Thermal Emission Spectroscopy |
10.1.6.Impedance/Dielectric Spectroscopy |
10.1.7.Photoacoustic Spectroscopy |
10.1.8.Electromagnetic |
10.1.9.Fluorescence |
10.1.10.Polarimetry |
10.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Wearable |
10.2.2.Non wearable |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Diagnostic centres |
10.3.3.Home Care |
10.3.4.Ambulatory surgical centres |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Non-Invasive Glucose Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Raman Spectroscopy |
11.1.2.MIR/NIR (Mid/Near Infrared Spectroscopy) |
11.1.3.Optical Coherence Tomography |
11.1.4.Occlusion Spectroscopy |
11.1.5.Thermal Emission Spectroscopy |
11.1.6.Impedance/Dielectric Spectroscopy |
11.1.7.Photoacoustic Spectroscopy |
11.1.8.Electromagnetic |
11.1.9.Fluorescence |
11.1.10.Polarimetry |
11.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Wearable |
11.2.2.Non wearable |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Diagnostic centres |
11.3.3.Home Care |
11.3.4.Ambulatory surgical centres |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Non-Invasive Glucose Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Raman Spectroscopy |
12.1.2.MIR/NIR (Mid/Near Infrared Spectroscopy) |
12.1.3.Optical Coherence Tomography |
12.1.4.Occlusion Spectroscopy |
12.1.5.Thermal Emission Spectroscopy |
12.1.6.Impedance/Dielectric Spectroscopy |
12.1.7.Photoacoustic Spectroscopy |
12.1.8.Electromagnetic |
12.1.9.Fluorescence |
12.1.10.Polarimetry |
12.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Wearable |
12.2.2.Non wearable |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Diagnostic centres |
12.3.3.Home Care |
12.3.4.Ambulatory surgical centres |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Non-Invasive Glucose Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Raman Spectroscopy |
13.1.2.MIR/NIR (Mid/Near Infrared Spectroscopy) |
13.1.3.Optical Coherence Tomography |
13.1.4.Occlusion Spectroscopy |
13.1.5.Thermal Emission Spectroscopy |
13.1.6.Impedance/Dielectric Spectroscopy |
13.1.7.Photoacoustic Spectroscopy |
13.1.8.Electromagnetic |
13.1.9.Fluorescence |
13.1.10.Polarimetry |
13.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Wearable |
13.2.2.Non wearable |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Diagnostic centres |
13.3.3.Home Care |
13.3.4.Ambulatory surgical centres |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories (U.S.) |
14.2.2.ARKRAY, Inc. (Japan) |
14.2.3.Bayer AG (Germany) |
14.2.4.Dexcom, Inc. (U.S.), |
14.2.5.Hoffmann-La Roche Ltd (Switzerland) |
14.2.6.Johnson & Johnson (U.S.) |
14.2.7.Medtronic plc (U.S.) |
14.2.8.Nipro Diagnostics, Inc. (U.S.) |
14.2.9.Terumo Medical Corporation (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players